Q1 adj. EBIT -1% vs ABG, but -10% vs. consensus We cut adj.
Redeye updates on G5 Entertainment post Q1-result which saw lower revenue than expected.
Redeye comments on G5’s Q1-results which saw a weaker topline than expected and while reported EBIT was also below our estimate, the underly...
We expect positive organic growth from H2'25 EBIT estimates cut 2%, mainly on FX Share is trading at 6-5x and 10-11% FCF yields on '25e-'27e...
Redeye updates on G5 following its Q4-report where revenue was in line while EBIT was better than expected.
Redeye comments on G5’s Q4-results which saw revenue in line with our forecast while results where stronger supported by a solid gross margi...
Q4 due on 13 February Negative organic growth but +14% adj.
Q3 weaker, but entering Q4 with better momentum EBIT estimates cut by 3% on '25e-'26e Share is trading at 4x EV/EBIT and EV/FCF on 2025e We...
Redeye updates on G5 Entertainment post Q3-results which were weaker than expected.
Sales -6%, adj. EBIT -11% vs. FactSet consensus in Q3 We expect consensus to lower EBIT estimates by 2-4% on '25e-'26e Highlights positive m...
Redeye comments on G5’s Q3-results which saw somewhat softer topline than expected while gross margin was strong, driven by continued solid ...
Redeye updates on G5 following its Q2-result which was somewhat weaker than expected.
Negative growth trend persists, but could improve from Q4'24e Potential for continued gross margin improvements Trading at 5x EV/EBIT and 4x...
Sales -1% vs. ABGSC, driving 7% adj. EBIT miss We see consensus estimates coming down 2-3% Conference call at 8:00 CET Q2 results Sales SEK...
Redeye comments on G5’s Q2-results which were slighlty lower than our forecasts while the company remains optimistic on its game pipeline wh...
We expect the negative growth trend to continue in Q2 Good cost control is protecting profitability and cash flow 6-5x EBIT and 15-14% FCF y...
Sales -4% vs. ABGSCe but adj. EBIT +1% in Q1 We cut sales by 5% and adj.
G5 reported lower-than-expected topline in Q1, while good cost control supported solid profitability and EBIT results close to our forecast.
Redeye comments on G5’s Q1-results where topline was softer than expected while solid profitability, driven by a strong gross margin and low...
Growth remains soft while we wait for new releases EBIT ests.
G5 reported weaker than expected growth in Q4 2023 and while recent and upcoming game launches support gradually improving topline, we have ...
- Adj. EBIT -21% vs ABGSC, -21% vs FactSet consensus - Consensus to cut EBIT by 5% - Staff reductions to support margins in 2024 Q4 results ...
Redeye comments on G5’s Q4-results which were weaker than expected driven by soft performance from own games yielding lower topline growth a...
We expect stable performance in Q4 (due 8 Feb) Do not expect any contribution from new game Twilight Land yet Share trading at 7x-6x EV/EBIT...
Redeye updates on G5 following the company’s Q3-results which came in lower than expected.
Sales in line, write-down of advances weighed on EBIT, FCF solid We cut '23e-'25e adj.
Redeye comments on G5’s Q3-results where revenue came in slightly below expectations while EBIT was weaker as it was impacted by write-downs...
Q3 due 8 Nov, we expect weaker growth A bit more cautious on growth and profitability Share trading at 8x P/E and 7x EV/FCF on '23e Q3e: So...
Redeye updates on G5 following its Q2-results where topline was soft while results were close to our forecasts.
Sales and adj. EBIT a tad weaker, but FCF strongerWe cut EBIT but raise FCF on lower capexShare trading at 9x P/E with 9% buyback/div.
Redeye comments on G5’s Q2-report where topline was somewhat soft while results were close to our forecasts.
Sales in line, EBIT +11% vs. ABGSCe, FX drivenOrganic growth -10% vs ABGSCe -8.
We expect a bit weaker organic growth in Q2 We cut FCF by 6%, 4% and 6% for '23e, '24e and '25e Share trading at 10x P/E and 9% FCF yield on...
Redeye updates on G5 Entertainment which saw softer topline growth than expected in Q1.
Solid Q1 overall, New Gen games a bit soft Margin expansion to drive 12% EPS CAGR '23e-'25e Strong balance sheet, trading at 10% FCF yield ...
EBIT SEK 40m, +3% vs.ABGSCe, -3% vs. cons. Continues with margin improvements and high FCF conversion A tad soft growth in New Gen, but also...
Redeye comments on G5’s Q1-results which came in weaker than expected due to soft growth and higher opex with the latter owing to a lower ca...
Q1 due 4 May; trends continue to look positive... .
Solid report; G5 Store gaining significant traction G5 delivered a solid Q4 report, with sales +0% and EBIT +2% vs.
Redeye updates on G5 following its Q4-results which came in below our expectations.
Redeye comments on G5’s Q4-result which came in slightly below our forecast while the proposed dividend was higher than expected.
A very solid report, sales and EBIT in line A very solid report from G5 today.
Q4 report due 09 Feb EBIT cut by 3%, 6%, and 4% for '22e-'24e Trading at 9x P/E with 9% FCF yield 2023e Hidden City stabilisation should su...
Redeye updates estimates and valuation in G5 following its Q3-results.
Sales & adj. EBIT above our expectations We cut adj.
Sales in line, adj. EBIT +18% vs. consensus One-time impairment of 73m hurt net profit Buybacks to continue Q3 details Sales SEK 360m (3% v...
Redeye comments on G5’s Q3-results where revenue and EBITDA was in line with expectations while EBIT was impacted by write downs.
Redeye updates on G5 ahead of its Q3-results (due 9 November) where we expect sequential growth as the company is helped by a strong USD/SEK...
Sherlock going strong with HC seeing seq. improvement Elevated RUB weighing on EBIT in 2022e and 2023e Share trading at 5.
Redeye updates estimates and valuation following G5’s Q2-results which came in weaker than expected, mainly on the back of higher-than-expec...
Sales in line, but profitability and outlook worse ‘22e, ‘23e & ‘24e adj.
EBIT SEK 1m vs ABGSCe 15m and cons 16m Estimates on ‘22e-‘24e likely to come down 5-10% UAC will be back to normal range from August Q2 d...
Redeye comments on G5’s Q2-results where topline came in slightly lower than expected while profit was weaker due to higher costs than expec...
Q2 report due on 11 August We cut ‘22e-‘24e EBIT by 17%, 5%, and 4% 14% FCF yield with positive growth outlook in ’23e-‘24e Q2 expectations...
Authorised to repurchase 5% of shares… … while the share trades at 13% FCF yield on 2023e Investments in Sherlock looks promising Authoris...
Redeye updates its view on G5 following its Q1-results where the company’s hiked near-term UA investments lead us to slightly lower near-ter...
EBIT +7% vs. ABGSCe; guides for increased UAC in Q2 We raise ‘23e-‘24e EBIT on higher growth for Sherlock Trading at 5x EV/EBIT and a 12% F...
Adj. EBIT +7% vs ABGSC, +11% vs cons UA/sales to increase to 35% in Q2… …lowering profit short term, but is accretive to growth Q1 details ...
Redeye comments on G5’s Q1-results which adjusted for extraordinary costs related to the war in Ukraine came in stronger than expected.
ABGSCe Q1: adj. EBIT +6% y-o-y and flat sales We cut ‘22e-‘24e EBIT by 6%-9% 5x 2022e EV/EBIT – a five-year low Q1: We forecast flat sales ...
Redeye updates its view on G5 following the company’s Q4 21-results which was in line with expectations.
Redeye comments on G5’s Q4-results which came in close to our expectations.
Q2 EBIT of SEK 43m, -30% vs. ABGSCe, -20% vs. cons.
Q2 EBIT SEK 43m, -30.4% vs. ABG, -20.0% vs. cons Prel.
Redeye comments on G5’s Q2-result. Both net sales and EBIT were somewhat weaker than expected.
ABGSC Q2’21e EBIT at SEK 62m, +14.5% vs. cons We keep estimates intact Maintaining DCF fair value of SEK 415-750 per share We expect Q2’21 t...
